Therapeutic TNF Inhibitors Exhibit Differential Levels of Efficacy in Accelerating Cutaneous Wound Healing

• Váldodahkkit: Yonghao Cao (Dahkki), Bohdan P. Harvey (Dahkki), Liang Jin (Dahkki), Susan Westmoreland (Dahkki), Jing Wang (Dahkki), Munish Puri (Dahkki), Yingli Yang (Dahkki), Holly M. Robb (Dahkki), Sultan Tanriverdi (Dahkki), Chenqi Hu (Dahkki), Xue Wang (Dahkki), Xiaofeng Xin (Dahkki), Yingchun Liu (Dahkki), Michael P. Macoritto (Dahkki), Kathleen M. Smith (Dahkki), Yu Tian (Dahkki), Kevin White (Dahkki), Timothy R.D.J. Radstake (Dahkki), Zehra Kaymakcalan (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Elsevier, 2024-01-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Adalimumab but neither etanercept nor certolizumab-pegol has been reported to induce a wound-healing profile in vitro by regulating macrophage differentiation and matrix metalloproteinase expression, which may underlie the differences in efficacy between various TNF-α inhibitors in impaired wound he...